Toolkit/membrane-tethered CRY2

membrane-tethered CRY2

Multi-Component Switch·Research·Since 2014

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Membrane-tethered CRY2 is a CRY2/CIB optical dimerization configuration in which CRY2 is localized at a membrane to control recruitment of CIB-linked partners with light. The reported application demonstrates that this arrangement is functional and may provide improved local control of protein interactions.

Usefulness & Problems

Why this is useful

This configuration is useful for spatially restricted optogenetic control because it places the CRY2 photoswitch at a membrane rather than in a diffuse cellular compartment. The cited study specifically suggests that membrane tethering may improve local control of protein interactions.

Source:

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions

Problem solved

It addresses the problem of controlling where light-induced CRY2/CIB interactions occur inside the cell. The reported use case indicates that membrane localization can be used to constrain inducible dimerization to a defined subcellular site.

Source:

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A composed arrangement of multiple parts that instantiates one or more mechanisms.

Techniques

No technique tags yet.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationimplementation constraint: multi component delivery burdenoperating role: actuatorswitch architecture: multi componentswitch architecture: recruitment

Implementation requires a multi-component CRY2/CIB design in which CRY2 is fused to a membrane-targeting element and the interaction partner is linked to CIB. The supplied evidence does not specify the membrane anchor, host system for this configuration, or detailed construct design.

Evidence for this specific membrane-tethered configuration is limited to a brief application statement from a single benchmarking study. Quantitative performance metrics, membrane identity, construct architecture, illumination parameters, and validation across organisms or assays are not provided in the supplied evidence.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 2application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 3application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 4application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 5application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 6application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 7application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 8application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 9application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 10application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 11application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 12application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 13application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 14application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 15application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 16application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 17application demosupports2014Source 1needs review

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions
Claim 18background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 19background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 20background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 21background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 22background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 23background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 24background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 25background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 26background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 27background activity comparisonsupports2014Source 1needs review

CRY2/CIB1 showed slightly less background activity in the dark than the TULIP system during regulation of a yeast MAPK signaling pathway.

with slightly less background activity in the dark observed with CRY2/CIB
Claim 28benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 29benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 30benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 31benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 32benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 33benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 34benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 35benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 36benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 37benchmark resultsupports2014Source 1needs review

CRY2/CIB1 and TULIPs showed similar responses in a yeast transcriptional assay.

but similar responses between the CRY2/CIB and TULIP systems
Claim 38benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 39benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 40benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 41benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 42benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 43benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 44benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 45benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 46benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 47benchmark resultsupports2014Source 1needs review

The red-light-regulated systems phyB/PIF3 and phyB/PIF6 showed significant differences in light sensitivity and fold-activation levels in a yeast transcriptional assay.

Using a yeast transcriptional assay, we find significant differences in light sensitivity and fold-activation levels between the red light regulated systems
Claim 48pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 49pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 50pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 51pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 52pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 53pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 54pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 55pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 56pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses
Claim 57pathway regulation comparisonsupports2014Source 1needs review

CRY2/CIB1 and TULIP systems showed similar responses when used to regulate a yeast MAPK signaling pathway.

Further comparison of the ability of the CRY2/CIB1 and TULIP systems to regulate a yeast MAPK signaling pathway also showed similar responses

Approval Evidence

1 source1 linked approval claimfirst-pass slug membrane-tethered-cry2
In addition, we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2

Source:

application demosupports

CRY2/CIB dimerizers were successfully applied using a membrane-tethered CRY2 configuration, which may allow better local control of protein interactions.

we demonstrate successful application of the CRY2/CIB dimerizers using a membrane-tethered CRY2, which may allow for better local control of protein interactions

Source:

Comparisons

Source-backed strengths

The available evidence shows successful application of CRY2/CIB dimerizers in a membrane-tethered CRY2 format. More generally for CRY2/CIB1, the benchmark study reported slightly less dark background than the TULIP system in regulation of a yeast MAPK signaling pathway and similar responses to TULIPs in a yeast transcriptional assay.

Compared with optoPAK1

membrane-tethered CRY2 and optoPAK1 address a similar problem space.

Shared frame: same top-level item type; shared mechanisms: heterodimerization

Strengths here: looks easier to implement in practice.

Compared with Opto-RhoGEFs

membrane-tethered CRY2 and Opto-RhoGEFs address a similar problem space.

Shared frame: same top-level item type; shared mechanisms: heterodimerization

Strengths here: looks easier to implement in practice.

membrane-tethered CRY2 and two-photon-sensitive caging group for gibberellic acid activation address a similar problem space.

Shared frame: same top-level item type; shared mechanisms: heterodimerization

Strengths here: looks easier to implement in practice.

Ranked Citations

  1. 1.
    StructuralSource 1ACS Synthetic Biology2014Claim 12Claim 11Claim 11

    Extracted from this source document.